Why would an alternative to intravenous access be sought for drug administration in cases of out-of-hospital cardiac arrest? Previous trials have explored the clinical effectiveness of medications ...

Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods ...

Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

However, smart pumps prevented 668 moderate to severe harm administration errors (a rate of 0.9/1000 IV administrations) and included blood thinning medication, drugs affecting heart rhythm and drugs ...

ENHANZE can shorten the dose administration time of intravenous drugs when administered subcutaneously, from hours to minutes. • Herceptin SC administration reduces delivery time from ~30 ...